PL3237433T3 - Sposób wytwarzania białka - Google Patents
Sposób wytwarzania białkaInfo
- Publication number
- PL3237433T3 PL3237433T3 PL15813438.7T PL15813438T PL3237433T3 PL 3237433 T3 PL3237433 T3 PL 3237433T3 PL 15813438 T PL15813438 T PL 15813438T PL 3237433 T3 PL3237433 T3 PL 3237433T3
- Authority
- PL
- Poland
- Prior art keywords
- protein manufacture
- protein
- manufacture
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14199722 | 2014-12-22 | ||
| PCT/EP2015/080526 WO2016102378A1 (en) | 2014-12-22 | 2015-12-18 | Method of protein manufacture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3237433T3 true PL3237433T3 (pl) | 2025-12-08 |
Family
ID=52282495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15813438.7T PL3237433T3 (pl) | 2014-12-22 | 2015-12-18 | Sposób wytwarzania białka |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10626143B2 (pl) |
| EP (1) | EP3237433B1 (pl) |
| JP (1) | JP6807326B2 (pl) |
| KR (1) | KR102537099B1 (pl) |
| CN (1) | CN107108691B (pl) |
| AU (1) | AU2015371341B2 (pl) |
| BR (1) | BR112017013398B1 (pl) |
| CA (1) | CA2969981C (pl) |
| CL (1) | CL2017001633A1 (pl) |
| CO (1) | CO2017006157A2 (pl) |
| DK (1) | DK3237433T3 (pl) |
| EA (1) | EA039002B1 (pl) |
| ES (1) | ES3046837T3 (pl) |
| FI (1) | FI3237433T3 (pl) |
| HR (1) | HRP20251240T1 (pl) |
| IL (1) | IL252712B2 (pl) |
| LT (1) | LT3237433T (pl) |
| MX (1) | MX381459B (pl) |
| MY (1) | MY184085A (pl) |
| PL (1) | PL3237433T3 (pl) |
| PT (1) | PT3237433T (pl) |
| SG (1) | SG11201704841UA (pl) |
| SI (1) | SI3237433T1 (pl) |
| WO (1) | WO2016102378A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3237432T1 (sl) | 2014-12-22 | 2023-12-29 | UCB Biopharma SRL | Izdelava proteinov |
| EP3558363A1 (en) | 2016-12-21 | 2019-10-30 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CN110386978A (zh) * | 2018-04-19 | 2019-10-29 | 上海多米瑞生物技术有限公司 | 大肠杆菌周质空间表达的蛋白的提取方法 |
| CN111965356B (zh) * | 2019-11-28 | 2023-09-08 | 上海荣盛生物药业股份有限公司 | 巯基还原组合物及荧光微球层析试纸和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9215540D0 (en) | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
| US5655866A (en) | 1995-03-20 | 1997-08-12 | Bellanca; Joseph V. | Method of folding a signature for use in bookbinding |
| CA2364568A1 (en) * | 1999-03-17 | 2000-09-21 | Adrian Woolfson | Method for refolding molecules of polypeptides containing ig domains |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| JP5553963B2 (ja) * | 2004-10-22 | 2014-07-23 | アムジエン・インコーポレーテツド | 組換え抗体をリフォールディングする方法 |
| EP1805205A1 (en) * | 2004-10-22 | 2007-07-11 | Amgen Inc. | Methods for refolding polypeptides |
| GB0425534D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
| GB0513852D0 (en) | 2005-07-06 | 2005-08-10 | Celltech R&D Ltd | Biological products |
| ZA200900229B (en) | 2006-07-14 | 2010-04-28 | Genentech Inc | Refolding of recombinant proteins |
| EP2102355B1 (en) * | 2006-12-14 | 2016-03-02 | Bolder Biotechnology, Inc. | Long acting proteins and peptides and methods of making and using the same |
| GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| KR101853146B1 (ko) | 2010-03-17 | 2018-04-27 | 라티오팜 게엠베하 | 생물학적으로 활성인 재조합 인간 gcsf의 수득 방법 |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| GB201012603D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
| CA2815342A1 (en) | 2010-10-20 | 2012-04-26 | Medimmune, Llc | Methods for processing inclusion bodies |
| SI3237432T1 (sl) | 2014-12-22 | 2023-12-29 | UCB Biopharma SRL | Izdelava proteinov |
| GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
-
2015
- 2015-12-18 PL PL15813438.7T patent/PL3237433T3/pl unknown
- 2015-12-18 IL IL252712A patent/IL252712B2/en unknown
- 2015-12-18 BR BR112017013398-9A patent/BR112017013398B1/pt active IP Right Grant
- 2015-12-18 ES ES15813438T patent/ES3046837T3/es active Active
- 2015-12-18 CA CA2969981A patent/CA2969981C/en active Active
- 2015-12-18 SI SI201532078T patent/SI3237433T1/sl unknown
- 2015-12-18 LT LTEPPCT/EP2015/080526T patent/LT3237433T/lt unknown
- 2015-12-18 EP EP15813438.7A patent/EP3237433B1/en active Active
- 2015-12-18 WO PCT/EP2015/080526 patent/WO2016102378A1/en not_active Ceased
- 2015-12-18 JP JP2017551008A patent/JP6807326B2/ja active Active
- 2015-12-18 AU AU2015371341A patent/AU2015371341B2/en active Active
- 2015-12-18 DK DK15813438.7T patent/DK3237433T3/da active
- 2015-12-18 SG SG11201704841UA patent/SG11201704841UA/en unknown
- 2015-12-18 CN CN201580070976.9A patent/CN107108691B/zh active Active
- 2015-12-18 PT PT158134387T patent/PT3237433T/pt unknown
- 2015-12-18 MX MX2017007670A patent/MX381459B/es unknown
- 2015-12-18 EA EA201791423A patent/EA039002B1/ru unknown
- 2015-12-18 MY MYPI2017702190A patent/MY184085A/en unknown
- 2015-12-18 FI FIEP15813438.7T patent/FI3237433T3/fi active
- 2015-12-18 US US15/538,282 patent/US10626143B2/en active Active
- 2015-12-18 HR HRP20251240TT patent/HRP20251240T1/hr unknown
- 2015-12-18 KR KR1020177020637A patent/KR102537099B1/ko active Active
-
2017
- 2017-06-20 CL CL2017001633A patent/CL2017001633A1/es unknown
- 2017-06-21 CO CONC2017/0006157A patent/CO2017006157A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249955A0 (en) | A method for the computational design of proteins | |
| IL252696A0 (en) | protein production | |
| GB201518792D0 (en) | Production of proteins | |
| GB201516516D0 (en) | Process of manufacture | |
| GB2522719B (en) | Method of manufacture | |
| GB201410116D0 (en) | Method of treatment | |
| GB201515557D0 (en) | Method of sequencing | |
| GB201515558D0 (en) | Method of sequencing | |
| HUP1400114A2 (en) | Method for the production of peptides | |
| IL253028B (en) | treatment method | |
| GB201904142D0 (en) | Improved method of FT-IMS | |
| IL252712A0 (en) | Method for protein production | |
| GB201609170D0 (en) | Method of manufacture | |
| PL3111151T3 (pl) | Sposób działania obrotowego pieca do wytwarzania spoiw hydraulicznych | |
| IL248999A0 (en) | A method for geolocation | |
| GB2522716B (en) | Method of manufacture | |
| GB201706346D0 (en) | Method of scoring | |
| GB201613971D0 (en) | Method of manufacture | |
| GB201609171D0 (en) | Method of manufacture | |
| GB2522904B (en) | Method of making an airdam | |
| GB201700973D0 (en) | Process of manufacture | |
| GB201602758D0 (en) | Method of manufacture | |
| GB201600334D0 (en) | Method of manufacture | |
| GB201600282D0 (en) | Method of manufacture | |
| GB201419990D0 (en) | Hprseshoe and method of manufacture |